Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 11/20 | 0.64 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.53 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.53 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | EPHX2 | P34913 | 5/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3581281 | 1.00 | EPHX1 (0.64) | EPHX1HDAC4HDAC1HDAC6GAA | |
| SCHEMBL25495471 | 0.96 | EPHX1 (0.63) | EPHX1HDAC4HDAC1HDAC6GAA | |
| SCHEMBL20010904 | 0.96 | EPHX1 (0.63) | EPHX1HDAC4HDAC1HDAC6GAA | |
| SCHEMBL17294057 | 0.81 | MEN1 (0.46) | EPHX1GAAMEN1KMT2AEPHX2 | |
| SCHEMBL17294055 | 0.81 | MEN1 (0.46) | EPHX1GAAMEN1KMT2AEPHX2 | |
| SCHEMBL8641550 | 0.81 | EPHX1 (0.52) | EPHX1HDAC4HDAC1HDAC6GAA | |
| SCHEMBL15727229 | 0.81 | GAA (0.50) | EPHX1HDAC4HDAC1HDAC6GAA | |
| SCHEMBL12954612 | 0.80 | MEN1 (0.62) | EPHX1GAAMEN1KMT2ATDP1 | |
| SCHEMBL29553272 | 0.80 | EPHX1 (0.46) | EPHX1HDAC4HDAC1HDAC6GAA | |
| SCHEMBL20804118 | 0.79 | EPHX1 (0.49) | EPHX1HDAC4HDAC1HDAC6GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100048549-A1 | Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4 | Wurster, Siegfried (FI) | 2010-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100048549-A1 | Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4 | SSTR1, SSTR4, SSTR3 | EPHX1 3831/4885HDAC4 1252/4885HDAC1 2227/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.